Angiosarcoma Global Clinical Trials Review, H2, 2018

Publisher Name :
Date: 31-Oct-2018
No. of pages: 115
Inquire Before Buying

Angiosarcoma Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, "Angiosarcoma Global Clinical Trials Review, H2, 2018" provides an overview of Angiosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Angiosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Angiosarcoma Global Clinical Trials Review, H2, 2018

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Angiosarcoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Angiosarcoma to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Angiosarcoma Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profile Snapshots 34
Appendix 113
Abbreviations 113
Definitions 113
Research Methodology 114
Secondary Research 114
About GlobalData 114
Contact Us 115
Disclaimer 115
Source 115

List of Tables
Angiosarcoma Therapeutics, Global, Clinical Trials by Region, 2018* 7
Angiosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Angiosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Angiosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Angiosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Angiosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Angiosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Proportion of Angiosarcoma to Oncology Clinical Trials, G7 Countries (%), 2018* 15
Angiosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Angiosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Angiosarcoma to Oncology Clinical Trials, E7 Countries (%), 2018* 19
Angiosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Angiosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Angiosarcoma Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Angiosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23
Angiosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Angiosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
Angiosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
Angiosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 28
Angiosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Angiosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Angiosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33

List of Figures
Angiosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Angiosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Angiosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Angiosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Angiosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Angiosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Proportion of Angiosarcoma to Oncology Clinical Trials, G7 Countries (%), 2018* 15
Angiosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Angiosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Angiosarcoma to Oncology Clinical Trials, E7 Countries (%), 2018* 19
Angiosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Angiosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Angiosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Angiosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23
Angiosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Angiosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
Angiosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
Angiosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 28
Angiosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29
Angiosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31
Angiosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33
GlobalData Methodology 114
  • Small Molecule Targeted Cancer Therapy Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Mar-2020        Price: US 3000 Onwards        Pages: 147
    Small Molecule Targeted Cancer Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Small Molecule Targeted Cancer Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Small Molecule Targeted Cancer Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides a......
  • Global Circulating Tumor Cells Market Status and Future Forecast 2015-2025
    Published: 20-Mar-2020        Price: US 4500 Onwards        Pages: 166
    Summary This report mainly covers Circulating Tumor Cells products, by types (CTC enrichment, CTC detection and CTC analysis), by applications (Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others). The report forecast global Circulating Tumor Cells market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Circulating Tumor Cells industry and main mark......
  • Endometrial Cancer Treatments Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 13-Mar-2020        Price: US 3000 Onwards        Pages: 135
    Endometrial Cancer Treatments Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Endometrial Cancer Treatments industry with a focus on the Chinese market. The report provides key statistics on the market status of the Endometrial Cancer Treatments manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-......
  • Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2020-2026
    Published: 11-Mar-2020        Price: US 3900 Onwards        Pages: 96
    This report focuses on the global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glioblastoma Multiforme Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - AbbVie, Inc - Activartis GmbH - Agenus Inc - Arog Pharmaceuticals, Inc - Bristol-Myers Squib......
  • Global Non-Hodgkin Lymphoma Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 10-Mar-2020        Price: US 3900 Onwards        Pages: 98
    This report focuses on the global Non-Hodgkin Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Hodgkin Lymphoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Bristol Myers Squibb - Celgene - Eli Lilly - F. Hoffman La-Roche - GlaxoSmithKline - ......
  • Global Melanoma Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 10-Mar-2020        Price: US 3900 Onwards        Pages: 94
    This report focuses on the global Melanoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Melanoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - AstraZeneca - Amgen, Inc. - F. Hoffmann-La Roche Ltd. - Bristol-Myers Squibb Company - Novartis AG - Merck & ......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2020-2025
    Published: 10-Mar-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Circulating Tumor Cells market will register a 21.2% CAGR in terms of revenue, the global market size will reach $ 2273.7 million by 2025, from $ 1055 million in 2019. In particular, this report presents the global revenue market share of key companies in Circulating Tumor Cells business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Circulating Tumor Cells market ......
  • Cancer Gene Therapy Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Mar-2020        Price: US 3000 Onwards        Pages: 146
    Cancer Gene Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Gene Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Gene Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Cancer......
  • Cancer Therapeutics and Biotherapeutic Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Mar-2020        Price: US 3000 Onwards        Pages: 146
    Cancer Therapeutics and Biotherapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Therapeutics and Biotherapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Therapeutics and Biotherapeutic manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs